Anthony Vega’s Weekly Opinion article, “Benefiting from Paul Mampilly’s Extraordinary Market Acumen” reveals the top picks from the successful investor, Paul Mampilly. Mampilly has picked a variety of winners working on Wall Street. However, he bases his investments on in-depth research into the history of the market, the history of the company, and other trends. He often spends weeks of intense hours researching the stock before recommending it.
Recently, Mampilly an active investor, is encouraging investors to look at three different niches for their future investments, namely food preferences, electric vehicles, and precision medicine.
Mampilly notes that there is a growing paradigm shift in the way Americans consume food. People are becoming more health conscious, but they still want the convenience and ease of having prepared meals. Prepared food and delivery kits are increasing their profits because of this. Many companies like Blue Apron and Plated, answer the need for both a health and simple meal. The companies provide the recipes and the ingredients so the consumers don’t need to go to the store or online to look for recipes. The millennial generation wants to have healthy options since they have seen the steep rise in diabetes, obesity and other metabolic issues. However, they are still willing to spend money on food. They want nutritious food without the hassle of grocery shopping.
Read more on prnewswire.com
Electric vehicles is also a great opportunity for savvy investors. Many traditional car companies may be on the fast track to extinction with the introduction of electric cars. Mampilly suggests that it will be a similar revolution as the iPhone with incredibly fast market displacement. The self-driving electric car will replace the traditional cars.
According to Bloomberg, medicine is also experiencing a shift in dynamics as they gain greater technological advances. With companies that can provide genome sequencing and data analytics of the individual patient’s medical history, medicine is about to get personal. These companies will allow doctors to diagnose medical conditions with more precision and provide personalized treatment that synthesizes the molecular and treatment information.
Paul Mampilly was born in India but educated in the states. He received his BBA from Montclair State University and his MBA from Fordham Gabelli School of Business. Mampilly has over 25 years of experience as an investor and hedge fund manager. He retired at 42 to spend more time with his family and focus on his newsletter, Profits Unlimited. The newsletter has over 90,000 readers who gain access to Mampilly’s in-depth knowledge and research.